NEW YORK (GenomeWeb News) – Quest Diagnostics today reported that its third quarter sales were down 2 percent year over year, in line with its pre-announcement made just last week.

The clinical lab and diagnostic information services provider reported revenues of $1.79 billion for the three months ended Sept. 30, down 2 percent year over year from $1.82 billion. Analysts had previously expected $1.84 billion in revenues for the quarter.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

David Dobbs writes at Buzzfeed that genomics has delivered little on its promises.

In PNAS this week: co-evolutionary signatures of insect hosts and bacterial symbionts, distinct transcript isoforms of high-grade ovarian cancer, and more.

Adam Rutherford discusses genetic genealogy at the Guardian.

Portions of the US 21st Century Cures Act are raising some safety concerns.